Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianpi Jiedu pill for psoriasis vulgaris
ChiCTR2200055593Phase 2Recruiting
- Sponsor
- Xinjiang Institute of Traditional Chinese Medicine
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Jianpi Jiedu pill in plaque psoriasis (2 arms), sponsored by Xinjiang Institute of Traditional Chinese Medicine. Primary endpoints: Psoriasis Area and Severity Index and Recurrence rate of psoriasis. Started Jul 2021; status: recruiting.
02
Drugs
Jianpi Jiedu pill
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR2200055593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055593.